Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Vividion secures clinical-stage WRN inhibitor from Roche
Bayer’s Vividion Therapeutics secured the global rights from its partner Roche to the only covalent WRN inhibitor to have made it into the clinic.
James Waldron
Jun 4, 2025 9:21am
Roche links BTK drug to low relapse rate across 96-week MS trial
May 30, 2025 5:19am
Roche taps Broad Institute to test SBX sequencing in the clinic
May 23, 2025 10:30am
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
May 21, 2025 8:30am
PureTech's deupirfenidone shows durable effect in IPF study
May 20, 2025 5:15pm
Roche to spend $550M building Indianapolis HQ into CGM hub
May 13, 2025 12:00pm
